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Transmissible gastroenteritis (TGE) is a coronavirus-induced disease of 
pigs, characterised by diarrhoea and vomiting. The incidence of the disease had 
been decreasing since the late 1980s when deletion mutant variants (porcine respi-
ratory coronavirus, PRCoV) of the virus emerged, repressing TGE gradually. Al-
though disease manifestations are infrequent, the virus is still present in pig herds, 
causing sporadic outbreaks in a milder form. Identification and characterisation of 
the spike genes from TGEV and PRCoV, detected in such outbreaks, were per-
formed in Hungary. Analysis of the amplified partial gene sequences showed that 
TGEV was present in herds with TGE clinical signs together with PRCoV. The 
sequences, apart from the deletions in PRCoV, were identical and at least two 
types of PRCoV spike proteins could be identified based on the length of the de-
leted sequence. 
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Porcine transmissible gastroenteritis (TGE) is caused by a coronavirus be-
longing into the Alphacoronavirus genus of the Coronaviridae family (de Groot 
et al., 2012). Coronaviruses are enveloped and contain the largest known single-
stranded viral RNA genome of positive polarity (26–32 kilobases, kb). TGE was 
first identified by Doyle and Hutchings (1946) and caused severe economic 
problems in the pig industry until the late 1980s, characterised by vomiting, diar-
rhoea and dehydration (Hooper and Haelterman, 1969) in younger pigs. Pigs in-
fected later in life may not even show clinical signs of the infection (Moon et al., 
1973). In Belgium, there was a dramatic increase in animals being seropositive 
for TGEV in 1984 without clinical signs associated with TGEV infection (Pen-
saert et al., 1986). TGEV could not be isolated from the seropositive animals; in-
stead, a new mutant of TGEV (porcine respiratory coronavirus, PRCoV) charac-
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terised mainly by deletions in the spike (S) protein (Rasschaert et al., 1990; Brit-
ton et al., 1991) emerged. PRCoV is pneumotropic, replicating mainly in alveo-
lar cells, but it can also replicate in the gastrointestinal tract in cells located un-
derneath the villi, and the infections are usually inapparent (Cox et al., 1990). 
There is a strong antigenic connection between TGEV and PRCoV. Sows 
infected with PRCoV secrete antibodies with the milk that are capable of de-
creasing the infection rate in the newborn gut, reducing clinical manifestation 
and consequently mortality of TGE (De Diego et al., 1994). Protective immunity 
on the antibody level against TGE is directed to the S protein of the virion. The 
spike is responsible for the attachment of the virus to cellular receptors. The ma-
jor such receptor is the ubiquitous aminopeptidase-N (Delmas et al., 1992) used 
both by TGEV and PRCoV, but another intestinal receptor for TGEV was sug-
gested by Weingartl and Derbyshire (1994) that can explain the age-limited sus-
ceptibility of pigs and the differences in pathogenicity of TGEV and PRCoV. One 
of the differences between TGEV and PRCoV is the deletion of variable size in the 
S gene (up to 681 nucleotides, Kim et al., 2000) that affects the intestinal binding 
of the virus either through the suggested receptor or by lacking the ability to utilise 
sialic acid when penetrating the mucus layer of the small intestine. The same dele-
tion is suitable for the differentiation of TGEV and PRCoV by molecular diagnos-
tic techniques (Paton et al., 1997) or by serology (Simkins et al., 1992). 
With the appearance and spread of PRCoV, the incidence of TGE gradually 
decreased. However, occasional reports of TGEV-specific seropositivity (Elvander 
et al., 2000; Brendtsson et al., 2006; Roic et al., 2012) and even sporadic outbreaks 
in different parts of the world (Pritchard et al., 1999; Kim et al., 2000; Miyazaki et 
al., 2010; Wang et al., 2010) indicate that TGE cannot be neglected, as the virus is 
still present in pig herds, although mostly without clinical manifestations. 
Recently, disease outbreaks characterised by vomiting and diarrhoea of 5–
7 days old suckling piglets were observed on a large sow farm in Hungary. Af-
fected litters were mainly those of gilts, but litters of some older sows showed 
similar clinical signs. These usually started with vomiting, then liquid, yellowish 
diarrhoea was seen, and emaciation, dehydration of the piglets developed rap-
idly. The disease spread rapidly to younger piglets in the room. Morbidity in 
some groups was estimated at about 50%, while mortality stayed low, at about 
4–6%. Sows were in good general condition, and liveborn litter sizes and piglet 
birth weights were within acceptable limits. The farm was run according to strict 
hygienic standards. It was not possible to relate outbreaks of vomiting and diar-
rhoea to sow feed composition or to particular farrowing rooms. The problem 
was more frequently observed from late autumn to early spring. Other age 
groups on the farm did not experience a similar condition. The herd was free of 
the main infectious agents including PRRSV, Aujeszky’s disease virus, My-
coplasma hyopneumoniae, Actinobacillus pleuropneumoniae serotypes 1 and 2, 
and Brachyspira hyodysenteriae. 
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The purpose of the present study was to screen the affected animals for the 
presence of coronaviruses (PRCoV and TGEV), and to characterise the potential 
differences in the spike gene sequences of these viruses. 
 
 
Materials and methods 
Samples 
Four clinically affected, untreated piglets of 4–6 days of age were sacri-
ficed and dissected on the farm. Samples were collected from the gastrointestinal 
tract and parenchymal organs for histopathology and immunohistochemistry (not 
shown). Samples for aerobic bacteriological culture, detection of clostridia and 
other common pathogenic anaerobic bacteria and viruses were also collected 
from the small and large intestines. After the detection of the first TGEV-
positive cases, a wider survey was initiated, where samples of small intestines, 
faeces and lung tissues were collected from 150 animals of the most susceptible 
age group. These samples were gathered at 14 different farms throughout the 
country, including the original farm. All of the farms were infected with porcine 
circovirus type 2 (data not shown). 
At the farm where the first TGEV-positive piglets were found, blood sam-
ples intended for serological examination were drawn from 15 gilts and 15 mul-
tiparous sows nursing affected litters. These samples were tested for the presence 
of anti-TGEV antibodies with a TGEV/PRCoV differentiating commercial ELISA 
(Svanovir® TGEV/PRCV-Ab ELISA, Svanova, Sweden) as described by the manual. 
Reverse transcriptase polymerase chain reaction (RT-PCR) and cloning 
About 0.1 g of the tissues or the faecal samples was used for nucleic acid 
extraction with the Viral Gene-spin™ Viral DNA/RNA Extraction Kit (iNtRON 
Biotechnology Inc., Korea) as recommended by the manufacturer using 0.5 µl of 
20 mg/ml Proteinase K (Fermentas, Lithuania). Reverse transcription of the RNA 
templates was performed with the M-MuLV RevertAid™ Reverse Transcriptase 
using random hexamer primers (100 pmol/sample) (Fermentas, Lithuania). 
The PCR primers used for the amplification and differentiation of the S gene 
from TGEV or PRCoV were designed using the Primer 3 program (Rozen and 
Skaletsky, 2000) based on the TGEV Purdue 115 full genome sequence (GenBank 
Accession Number: DQ811788), where the S gene is located at 20354–24697 nu-
cleotides (nt). The primers were TGE2: 5’-TAAGGAAGGGTAAGTTGCTCA-3’ 
(binding at 20282–20301 nt) and TGE3: 5’-TGGTCCATCAGTTACGCCGAA-3’ 
(21538-21518 nt) flanking a 1218-base fragment of the TGEV-S gene, covering the 
usual deletion sites of PRCoV-S. The reaction mixtures contained 1 μl cDNA, 1 μl 
of each primer (25 pmol), 1 μl of dNTP (1 mmol), 1 unit DreamTaq DNA poly-
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merase (Fermentas, Lithuania) and 5 μl of 10x DreamTaq Buffer (Fermentas, 
Lithuania) in a final volume of 50 μl. The amplification was done in a TGradient 
Thermocycler (Biometra, Germany). Molecularly cloned TGEV-S gene (Tuboly et 
al., 1994) was used as positive control. 
The steps of the PCR were as follows: 5 min at 95 °C, followed by 40 cy-
cles of denaturation at 95 °C, annealing at 55 °C (both for 30 sec) and elongation 
at 72 °C for 1 min, with a final step at 72 °C for 7 min. The amplicons were ana-
lysed in 2% agarose gels by electrophoresis. PCR fragments of sizes characteris-
tic of TGEV- or PRCoV-S genes were molecularly cloned using the TOPO® TA 
Cloning® Kit (Invitrogen, USA) following the instructions of the manufacturer.  
Sequence analysis 
The purified DNA clones were sequenced at the Biomi Ltd. (Gödöllő, 
Hungary) using the Big Dye® DirectCycle Sequencing Kit (Invitrogen, USA), 
with the universal M13 reverse and forward primers, in an ABI310 automated 
sequencer. Sequences were edited and aligned using the BioEdit (Hall, 1999) and 
MEGA5 software products (Tamura et al., 2011), and compared to known TGEV 
and PRCoV S gene sequences of the GenBank. 
 
 
Results 
Pathology and histopathology 
Gross pathological lesions, found in piglets that succumbed to the disease or 
had to be euthanised due to terminal illness, were weight loss and signs of dehy-
dration. The distended small intestinal loops and large intestines were filled with 
yellowish fluid. Mesocolonic oedema also occurred. Histopathology of the small 
intestinal tract did not reveal major changes apart from mild shortening of the villi. 
Crypt hyperplasia was not evident in the cases examined and the colonic mucosa 
appeared normal. Parenchymal organs did not show pathognomonic alterations. 
Common pathogens (pathogenic Escherichia coli, Clostridium perfringens C) 
were not detectable in any of the samples, while others (Clostridium perfringens A, 
Clostridium difficile A/B toxins) were detected in a small subset of these samples. 
Reverse transcriptase polymerase chain reaction 
The results of the RT-PCRs indicated that out of the 150 samples originat-
ing from 14 different swine herds only four herds were TGEV positive. Seven 
herds were positive for PRCoV only and three were negative both for TGEV and 
PRCoV. The farms could be divided into three groups based on their TGEV/ 
PRCoV profiles. 
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In the first group, pigs that suffered from clinical signs associated with en-
zootic TGE usually had either PRCoV- or TGEV-S gene sequences in their sam-
ples. These gene fragments were estimated by electrophoresis to be 550 base 
pairs (bp) and 1250 bp, for PRCoV- and TGEV-S genes, respectively. Mixed in-
fections were rarely detected. The PRCoV-S gene fragments were uniform in size. 
The second group also consisted of animals showing clinical signs of en-
zootic TGEV infection but in this group S genes of a variety of sizes were de-
tected. Besides the full-size fragment of the original TGEV-S (1258 bp, con-
firmed by sequencing), a variety of smaller-sized fragments were also detected, 
the dominant among them being a fragment with an approximate size of 600 bp 
and another of 250 bp, as judged by agarose gel electrophoresis. These three 
fragments were selected for cloning and sequencing. Besides these three S gene 
variants, others of intermediate sizes were also detected, but the cloning of these 
minor fragments was unsuccessful, or the obtained sequence did not show any 
homology with coronavirus genomes (data not shown). The original full-size 
fragment of the TGEV-S was found together with the smaller fragments in the 
same animal, which sets this group apart from the first one. 
Animals of the third group did not show clinical signs of enzootic TGEV 
infection. On these farms the TGEV-S gene was not detected. The S gene ampli-
cons were of approximately 550–600 bp in length, consistent with what would be 
expected in PRCoV-positive animals, but smaller fragments were also present. 
When comparing the presence of TGEV and PRCoV in different organs 
such as the small intestine, lungs or lymph nodes, no difference could be ob-
served. Usually lung and gut tissues or intestinal contents carried the virus. 
Hence, organ preference or tropism could not be established. 
Sequence analysis 
The largest fragment was 1258 bp as expected (GenBank No.: KC800687), 
the middle one had a size of 586 bp (GenBank No.: KC800688), while the shortest 
S gene amplicon was 283 bp in length. 
The GenBank search of these nucleotide sequences showed that they were 
98–99% identical to the viruses of the PUR46-MAD type (Sanchez et al., 1992) 
and fully identical on the predicted amino acid level with the corresponding area 
of the Chinese virulent field strain WH-1 (ADY39740). When comparing the 
amplicons to one another, it was obvious that the same coronavirus existed in at 
least three different forms if looking only at the S gene. Namely, the full-length 
TGEV-S type, a shorter one with a 672 nt deletion at the amino terminal half 
coding region of the S gene, and a further deletion mutant where the deletion was 
extended with an additional 303 nt towards the 3’ end of the gene. Still, all of 
these variants carried the sequence characteristics of the TGEV identified during 
this study, when only looking at the non-deleted parts of the gene. All of these 
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deletions retained the functionality of the remaining portion of the S protein, as 
the number of nucleotides missing did not alter the reading frame of the gene. 
Serology 
The results are summarised in Table 1, where the ELISA positivity of pigs 
from the original TGEV cases is shown for both TGEV and PRCoV. The major-
ity of the gilts were seropositive for porcine coronavirus and 6 out of 11 animals 
showed TGEV positivity at the threshold level. The older sows all seroconverted 
against porcine coronavirus and only 2 out of the 15 animals tested were sero-
negative for TGEV. 
Table 1 
ELISA results from blood samples collected from 15 gilts and 15 older sows in a TGEV–PRCoV 
differentiating test 
 TGEV PRCoV 
Gilts Positive Suspect Negative Positive Suspect Negative 
No. 0 6 9 11 0 4 
% 0 40 60 73.3 0 26.67 
Older sows Positive Suspect Negative Positive Suspect Negative 
No. 5 8 2 15 0 0 
% 33.33 53.33 13.33 100 0 0 
 
 
Discussion 
The first appearance of transmissible gastroenteritis (Doyle and Hutchings, 
1946), when pig herds without any immunity encountered the virus, was devas-
tating. This epizootic form of the disease was typical in newly affected herds, 
with 100% mortality rate of newborn animals. In older animals the clinical signs 
were restricted to mild diarrhoea and decreased production. As the epizootic pro-
ceeded worldwide and more and more herds seroconverted, the mortality rate 
dropped to 10–50% in newborns, depending on maternal antibody levels. Still, 
even with its sporadic epizootic and characteristic enzootic form TGE was one of 
the major viral diseases of the swine industry until the appearance and gradual 
spread of the mutant PRCoV strains. The origin of PRCoV is not known; it was 
suspected that some attenuated TGEV vaccine started an individual spread 
worldwide, but the sequence differences and the dissimilarities in the site and 
size of deletions among the identified strains indicated otherwise (Tuboly, 1996). 
Although the PRCoV-induced antibodies provide only limited protection 
against TGEV, the constant presence of the new virus and the PRCoV antibodies 
resulted in a decrease of the incidence of clinical TGE in PRCoV-infected herds. 
By the mid-1990s only sporadic cases of TGE were reported. Today TGE is usu-
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ally considered as a disease of the past. However, there have been occasional re-
ports of TGEV seropositivity (Elvander et al., 2000; Brendtsson et al., 2006), in-
dicating that the virus was still present, but at levels below the threshold of clini-
cal manifestation. 
Based on the results of this study, the herd where clinical signs and histo-
pathology first raised the suspicion of a TGEV infection was indeed proven to be 
TGEV positive, both by serological and PCR tests. In the TGEV-positive cases, 
mild villous atrophy was seen without any other significant gross or microscopic 
alteration. Group 1 coronavirus (Alphacoronavirus 1) immunohistochemistry 
(not shown) on small intestinal samples gave dubious results. When the survey 
was extended to other herds, the presence of TGEV could be confirmed with 
PCR in four pig farms. From the re-emergence of the disease one would expect 
that a new, perhaps more virulent TGEV strain is spreading, one that is capable 
of breaking through the immunity induced by PRCoV. However, the sequencing 
results indicated that the viruses were very similar to already known TGE vi-
ruses, namely to those of the PUR46-MAD strain (Sanchez et al., 1992). In order 
to decide if this truly is a new genetic variant of the virus with higher virulence, 
other regions of the genome must also be amplified and sequenced. 
The PRCoV sequences detected in this study could be separated into two 
different groups: one with a 672 nt deletion and one where the deletion was alto-
gether 975 nt long. The 672 nt deletion (compared to the TGEV-S gene) was 
identical to what was observed for the PRCoV strains widespread in Europe, 
where a 224 amino acid (aa) coding region was deleted starting at the position of 
amino acid number 21 of the S gene. It is, however, peculiar that after several 
years of establishing the genetic characteristics of the PRCoV strains in Europe 
the same deletion mutant is still present in pig herds. 
The presence of the PRCoV genomes with an even longer deletion within 
the S gene was surprising as such large deletions starting at the same site as the 
previous one and extending 303 nt further into the 3’ direction have not been re-
ported previously. This raises the question whether such deletion mutants can form 
infectious particles, or if they can only survive when packaged into virions pro-
duced by co-existing longer genomes. The possibility that this deletion mutant re-
mains infective is likely as the 975 nt deletion by itself should not thwart virus in-
fection. This is so because the aminopeptidase-N binding site is encoded further 
downstream on the sequence as compared to the end of the deletion. Without struc-
tural studies of such an S protein variant it is of course difficult to tell how the lack of 
such a long protein stretch may change the conformation of the receptor binding site. 
Our results cannot explain the re-emergence of the virus in clinical condi-
tions, but from this limited survey it seems that primiparous sows did not com-
pletely seroconvert to TGEV, therefore their piglets were probably not fully pro-
tected. PRCoV seronegativity was detected in a limited number of primiparous 
sows, indicating that cross-protection might also be suboptimal. These results in-
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dicate that the answer to why TGE is re-emerging lies not within the genetics of 
the virus but most likely in the immune response of the pigs. It is known that 
porcine circoviruses (PCV) are present worldwide and they are strongly immu-
nosuppressive (Ramamoorthy and Meng, 2009). Vaccine- or infection-induced 
immunity is generally limited in heavily infected pig herds, even if the clinical 
signs of circovirus infection are not apparent. Although we have no direct proof 
of this assumption, namely that the presence of PCV is responsible for the TGEV 
problem, serological results (Table 1) showed that primiparous pigs may remain 
seronegative for both TGEV and PRCoV. Similar increases of TGE incidence 
have been reported from Japan (Miyazaki et al., 2010) and China (Wang et al., 
2013), the world’s largest pork producer. 
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